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ABBREVIATIONS 
 
Abbreviation  Meaning  
APH Antepartum haemorrhage  
AKMICH Al Kharj Military Industries Corporation Hospital  
BT Blood transfusion 
C.T  Computerized tomography  
C/S  Caesarean section   
FHR Fetal heart rate 
gm/dl  Gram/deciliter  
GIT Gastrointestinal tract  
Hb Haemoglobin 
ICU Intensive Care Unit  
IVH Intraventricular haemorrhage 
IUFD Intrauterine fetal death  
KTH Khartoum Teaching Hospital  
Kgm Kilogram  
MRI Magnetic resonance imaging  
NICU Neonatal Intensive Care Unit  
NND Neonatal death  
NEC Necrotizing enterocolitis  
OMH Omdurman Maternity Hospital  
PPH Postpartum haemorrhage  
PP Placenta praevia  
PPA Placenta praevia accreta  
RR Relative risk 
RCOG Royal College of Obstetrician and Gynaecologist  
RDS Respiratory distress syndrome  
  
 
RKH Riyadh AlKharg Hospital  
SCBU Special Care Baby Unit  
SUH Soba University hospital  
TVS Trans-vaginal scan  
TAS Trans-abdominal scan 
U/S Ultrasound  
UTI Urinary tract infection 
Vs Versus  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
ABSTRACT 
 
This is a prospective, descriptive study conducted among 
two different groups of patients in two different countries. 
The first group was carried at AKMICH in K.S.A during the 
period between June 1999 to July 2003. The second group was at 
three big hospitals in Khartoum State (SUH, KTH, OMH) in the 
period between January 2005 to August 2005.  
The aim of the study was to assess the risk factors of PP, 
maternal complications and neonatal outcome and to perform a 
comparison between the two groups of the study.  
In the first group of the study the incidence of PP and PA 
were 5 in 1000 and 0.5 in 1000 pregnancies respectively, while in 
the second group the incidence were 2.8 per 1000 pregnancies 
and 0.3 per 1000. 
 An association between PP and high parity was found in 
both studied (P = 0.006 in the first group and P = 0.000 in the 
second group). Also the incidence of PP was directly proportional 
to the maternal age in the first and second groups (P = 0.001, and          
P = 0.004 respectively).  
Previous C/S was found to be a risk factor for PP in the 
second group (P = 0.038), while high percentage of the first group 
had previous one or more C/S (48.4%).  
In both groups there was high rate of maternal 
complications. In the first group obstetric haemorrhage (32.8%), 
caesarean hysterectomy (6.3%), BT (32.8%), hemoglobin less than 
10 gm/dl (53.1%), prolonged hospital stay (mean 6.52 ± 1.76 
  
 
days). In the second group the rate was 63.5%, 13.5%, and 61.5%  
and mean was 10.0 ± 1.12 respectively. There was one maternal 
death in the second group (1.9%), while in the first group no 
maternal death was found. 
In both studies PP was associated with adverse perinatal 
outcome. In the first group there was a significantly higher rates of 
prematurity, admission to SCBU, NICU, Apgar score less than 7 in 
5 minutes (P = 0.000; P = 0.001 and P = 0.001) respectively.  
There was no significant difference in perinatal mortality in 
this group (P = 0.089). 
The second group also showed significantly higher rates of 
prematurity, admission to SCBU, NICU, Apgar score <7 at 5 
minutes and increased perinatal mortality (P = 0.000; P = 0.000;       
P = 0.007 and P = 0.000) respectively.  
The study concluded that PP is associated with adverse 
maternal and neonatal outcome. Increased maternal age, high 
parity and previous C/S were risk factors.       
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INTRODUCTION AND LITERATURE REVIEW 
 
Placenta praevia (P.P) exists when the placenta is inserted 
wholly or in part into the lower segment of the uterus at or after 24 
weeks gestation, if covers the cervical os, it is considered a major 
or complete praevia. The term praevia should be restricted to cases 
where placental edge is ≤ 2 cm from the internal cervical os.(1)  
According to its relation with the uterine cervix, placenta 
praevia is classified into:  
• Complete placenta praevia; the placenta completely covers the 
internal cervical os.  
• Partial placenta praevia; the placenta partially covers the 
internal cervical os.  
• Marginal placenta praevia; the placenta is implanted at the 
margins of the internal os.  
The exact cause of placenta praevia is unknown, and the 
lower implantation of the placenta may be only by chance. The 
incidence of P.P at term is in the range of 3 to 6 per 1000 
pregnancies.(2)  
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Risk factors for placenta praevia include:  
• Advanced maternal age.  
• High parity.  
• Multiple pregnancy (large placental size).  
• Previous induced and spontaneous miscarriages.  
• Previous uterine scars (hysterotomy, myomectomy, and lower 
segment caesarean scar), this may be attributed to:  
- Alteration of the blood supply to the area.  
- Change in the depth and quality of the endometrium.  
- Change in the contour and shape of the uterine cavity.  
 Diagnosis is determined by ultrasonic imaging techniques. 
Transabdominal ultrasound scan (TAS) is the conventional but 
recently transvaginal ultrasound scan (TVS) and translabial scan 
(TLS) are found to be more accurate and reliable.(3) TVS compared 
to TAS is more reliable, does not need full bladder and is of special 
advantage with posterior situated placenta. In the situation of TAS 
the ultrasound waves may be rejected back by the culvarum and 
may be difficult to delineate the lower edge of the placenta. TVS 
makes visualization of posterior low lying placenta very easy and 
  3
the relation of the placental edge to internal os can be determined 
accurately. Additional benefit is reduced scanning time in TVS.  
Another condition related with P.P. is vasa praevia. This 
rare condition can cause antepartum haemorrhage (APH) and its 
diagnosis is usually missed. It occurs when there is velamentous 
insertion of the cord and the vessels lie on the membranes 
covering the internal os infront of the presenting part. It causes 
vaginal bleeding when the membranes rupture. The blood loss is 
foetal, and this when suspected can be confirmed by testing for 
foetal haemoglobin (FHb). There are few reports of diagnosing this 
condition by TVS with color Doppler in women with risk factors 
such as bilobed or succenturiate placenta, low lying placenta, 
multiple pregnancy or pregnancy resulting from in vitro 
fertilization (IVF).(4)   
Placenta accreta: 
Placenta accreta occurs when there is a defect of the decidua 
basalis resulting in abnormally invasive implantation of the 
placenta and morbid adherence into the myometrium. The 
resultant incomplete separation of the placenta may lead to 
massive haemorrhage. Furthermore, placenta accreta is associated 
  4
with high maternal mortality and morbidity. The incidence of P.A 
has increased 10 fold in the past 50 years and now occurs with a 
frequency of 1 per 2,500 deliveries. Women who had two or more 
caesarean deliveries with anterior or central placenta praevia have 
nearly a 40% risk of developing placenta accreta.(5) 
Evidence suggests that magnetic resonance imaging (MRI) 
and grey scale ultrasound may be useful to define an abnormally 
implanted placenta.(6) Still these methods are not conclusive and 
diagnosis may not be reached even after applying these methods. 
If the diagnosis or strong suspicion of placenta accreta is formed 
before delivery, the patient should be counseled about the 
likelihood of hysterectomy and blood transfusion. Blood products 
and clotting factors should be available as well as appropriate 
location and timing for delivery to allow access to adequate 
surgical personnel and equipment. A preoperative anaesthesia 
assessment should be obtained.  
Normally spontaneous detachment of the placenta occurs in 
90% of patients within 15 minutes, 95% within 30 minutes. Any 
further delay in its delivery should be considered either due to 
retention or morbid adherence. The exact causes of placenta 
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accreta are not known, but both trophoblastic invasion and 
defective or missing decidual layer have been suggested as 
possible causes of its morbid adherence. 
Risk factors associated with placenta accrete include:- 
• Previous lower segments caesarean section (C/S). 
• Placenta praevia. 
• Grandmultiparity. 
• Previous vigorous curettage. 
The grading of this condition is related to the depth of 
invasion, and the terms used are:(7) 
• Placenta accreta: the placenta is partially or completely 
adherent to the uterus with penetraton of the villi into the 
superficial part of the myometrium. 
• Placenta increta: the villi penetrate deeply through the 
deciduous into the myometrium. 
• Placenta percreta: penetration can even be seen on the serosal 
surface. 
Placenta accreta also can be classified according to the 
amount of placental involvement into:(8) 
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• Focal adherence; a single cotyledon is involved. 
• Partial adherence; several cotyledons are involved. 
• Total adherence; the entire placenta is involved. 
Lower segment C/S is the most identifiable risk factor and 
there is a well-documented association between placenta praevia, 
previous C/S and the development of placenta praevia accreta. 
Mellor et al found the risk of placenta accreta ranged 2% in 
women < 35 years with no previous C/S deliveries to almost 39% 
in women with two or more C/S deliveries.(9) 
In a retrospective study by Clerk et al(10) to assess the 
relationship between increasing number of previous C/S and the 
development of placenta praevia and placenta accreta, they found 
that in women with one uterine incision, the risk of placenta 
praevia was 0.26% compared with 10% in women with four or 
more uterine incisions.(7) In the same study they found that, the 
effect of advancing age and parity on the incidence of placenta 
praevia was less significant.  Zaki et al(11) have conducted a 
retrospective study in Abha Maternity Hospital in Saudi Arabia to 
assess the risk factor and morbidity of placenta praevia accreta.  
The records of all patients delivered by c/s for placenta praevia 
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were reviewed in the period from 1990-1996, out of 23070 
deliveries, 110 (0.48%) had placenta praevia, 12 (0.05%) had 
placenta praevia accreta.  They found that there was no significant 
difference in age and parity.  In the study they found also that the 
incidence of placenta praevia accreta increased linearly from 4.1% 
in patients with no scars to 60% in patients with 3 or more C/S.  
Emergency hysterectomy and PPH were significantly higher 
among the praevia accreta patients compared with praevia alone. 
In contrast Lyasu et al found the incidence of PP to be 
higher in women aged 35 years or more than in women less than 
20 years.(12) If the likelihood of placenta praevia increases with the 
greater number of caesarean deliveries, this finding would 
support the idea of the causal relationship between prior C/S 
delivery and PP. 
Ananth et al in a study to determine the incidence of PP and 
to identify the risk of its development based on the presence and 
number of C/S deliveries and history of induced or spontaneous 
miscarriages(13,2). They reported the incidence of PP ranged 
between 0.28% and 2%.  In the same study they found that women 
with at least one prior C/S delivery were 2.6 times at greater risk 
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for development of PP in a subsequent pregnancy. In another 
study women with history of spontaneous or induced 
miscarriages had a relative risk of PP of 1.6 and 1.7 respectively. 
Johnson et al in a retrospective study to assess the effect of 
curettage on PP concluded that, the risk of PP may be increased in 
a close response fashion by multiple sharp curettage 
miscarriages.(14) However, vacuum aspiration does not confer on 
increased risk, and may be a better alternative. Einola et al also 
found a similar relation.(15) 
Benirschke and others have theorized that patients with 
twin gestations are at increased risk of development of PP because 
of limited uterine space and increased placental mass.(16) 
Brenner et al reported a significantly higher rate of PP in 
women carrying twin pregnancy.(17)  Strong and Barr(18) supported 
this but Spellacy et al found no increased risk of PP among twin 
gestations.(19) In addition an English Language Medline Search 
failed to identify any study that has evaluated whether high order 
multiple gestations are at increased risk for PP development. 
Francois et al found that, outcome and complications of PP 
do not differ between singleton and multiple gestation.(20) 
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Clinical presentation: 
Vaginal bleeding: 
Placenta praevia is much more common in early pregnancy 
than at term.  PP classically is characterized by painless vaginal 
bleeding in the late 2nd or 3rd trimester.  However, uterine pain 
and/or contraction do not exclude the diagnosis in women with 
vaginal bleeding.  The first haemorrhage usually is not severe (the 
warning haemorrhage), although this is not invariable and 
sometimes it may be so profuse.(8) 
• Asymptomatic: during the routine 2nd trimester U/S, the 
placenta is observed to cover the cervix in 5-20% of 
pregnancies.  However, because of the growth of the uterus 
throughout the pregnancy, more than 90% of early PP convert 
to a normal location by the time of delivery.  Conversion to a 
normal location is less common in centrally located complete 
PP. 
• Abnormal fetal presentation: is observed in up to 30% of cases.  
As the placenta occupies the lower uterine segment, thus 
preventing the presenting part from getting engaged, high 
head, breech presentation, transverse or oblique lie are 
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encountered. In asymptomatic cases they become more 
significant in suspecting the presence of PP, the longer they 
persist in late pregnancy. Lam CM et al(21) from princess 
Margaret Hospital, Hong Kong conducted a retrospective 
study to evaluate the maternal and neonatal outcomes of 
women with PP and APH, compared with women with a 
diagnosed PP who did not bleed. They found the majority of 
women with bleeding had an emergency C/S for APH and 
more delivered early because of fetal distress.  The mean birth 
weight was lower in women with APH.  More infants in the 
bleeding group had a low Apgar score at the first minute, 
respiratory distress syndrome (RDS) and admission to Special 
Care Baby Unit (SCBU) and Neonatal Intensive Care Unit 
(NICU). It is concluded that there is an increased risk of 
premature delivery in women with APH and PP. 
• Clinical examination: the general condition of the patient is 
usually good, as the first attack of bleeding is usually slight.  
Abdominal examination shows the uterus to be soft and not 
tender.  The foetal heart rate (FHR) is usually normal.  
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• Placenta accreta: PA should be suspected in all women with 
PP.   9-10% of cases of PP are associated with PPA. In the 
majority of cases, PA remains asymptomatic until delivery. 
Although bleeding prior to labour is not uncommon, it is more 
likely to be related to PP than accreta.  A definitive diagnosis of 
accreta is not possible prior to delivery.  However, it may be 
possible to detect accreta with TVS. In cases delivered vaginally 
they may present either as a retained or partially separated 
placenta with severe PPH. Placenta praevia accreta may 
present as severe intraoperative bleeding due to difficulty in its 
removal and may necessitate caesarean hysterectomy as a life 
saving procedure. 
Management: 
Symptomatic PP:  
Management depends on the stage of pregnancy and the 
extent of haemorrhage.  The aim of conservative treatment for 
such cases is prolongation of pregnancy to achieve maturity 
whenever possible.  Macafee (1945) proposed a regieme required 
adherence to several principles which are: (22) 
• Admission of the patient once the diagnosis was made. 
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• Blood to be available and ready for transfusion whenever 
needed. 
• Anaemia to be looked for and corrected with blood transfusion 
(BT). 
• Facilities for emergency C/S to be available. 
Several attempts have been tried to prolong pregnancy by 
the use of tocolytics, which theoretically reduce the likelihood of 
bleeding by inhibiting uterine contractions and their impact in the 
lower uterine segments. 
Drugs used were:- 
• β-sympathomimetics (such as ritodrine) which was found to 
have side effects as maternal tachydcardia, hypoglycaemia and 
myocardial ischaemia. 
• Antiprostaglandins (Indomethacin) were used instead of 
retodrine but, they have side effects of causing maternal 
gastrointestinal (GIT) bleeding and in the foetus premature 
closure of ductus arteriosus (DA). 
• Magnesium sulphate (MgSO4) also found to be cardiotoxic 
and may cause adult RDS.  Besinger et al(  ) in a prospective 
study found that, the use of tocolytics in cases of 
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symptomatic PP may be associated with clinically significant 
prolongation of pregnancy and increased birth weight.  
Sharma A et al(23) to study the effect of retrodrine therapy on 
maternal and perinatal outcome in a prospective randomized 
controlled clinical trial in a total of 60 women whose pregnancies 
ranged from 28 through 34 menstrual weeks. Prolongation of 
pregnancy and birth weight of the newborn were evaluated. They 
found the use of tocolysis in symptomatic PP was associated with 
significant prolongation of pregnancy and difference in birth 
weight. 
Cervical cerclage; also was tried by Arias (1988)(24) who in a 
randomized controlled trial of cervical cerclage in women 
presenting with APH due to PP before 30 weeks of gestation, 
found the cerclage resulting in longer mean gestational age at 
delivery and in consequence less neonatal morbidity from 
immaturity.   
Cabo et al(25) in a case control study to assess the role of 
cervical cerclage in prolongation of pregnancy found no 
statistically significant difference between the two groups studied. 
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The use of cervical cerclage to reduce bleeding and prolong 
pregnancy is not backed up by sufficient evidence to recommend 
this practice.(26) 
Asymptomatic placenta praevia: 
What to advice women with asymptomatic apparent PP, 
diagnosed at routine U/S examination is usually a great 
dilemma.(8)  In terms of timing of antenatal admission during the 
3rd trimester for those women with major PP, who have not bled, 
there is no evidence to dictate at what gestation this should occur, 
if at all. Current practice is variable, with conservative policies 
admitting women at around 34 weeks of gestation, while others 
are left till much later and some units admit only for delivery.(26) 
PP diagnosed by routine 2nd trimester U/S is managed 
expectantly. The likelihood of spontaneous resolution is greater 
than 90%. Strenuous activity may provoke bleeding and should be 
avoided.   
Placental localization should be re-evaluated at 28-30 
weeks.  If PP is still present, the same precautions should be 
followed.  If PP persists beyond 32-34 weeks, resolution by term is 
uncommon.  C/S is usually scheduled at a gestational age that will 
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maximize the likelihood of foetal maturity and minimize the risk 
of haemorrhage that may result from the normal onset of uterine 
contractions.  In patients who are not experiencing bleeding, 
amniocentesis may be performed at 34-36 weeks to assess foetal 
lung maturity. If the baby’s lungs are mature delivery is usually 
indicated. Otherwise, management is individualized based on the 
condition of the mother and the baby.  Waiting beyond 37 weeks is 
not likely to benefit the mother or the baby. If the following are 
present, immediate C/S is usually necessary:- 
•  Deterioration of the condition of the mother. 
•  Persistent heavy bleeding. 
•  Gestational age > 36 weeks. 
•  Estimated foetal weight (EFW) > 2500 gm. 
•  Foetal distress in a viable foetus. 
•  Contractions that do not respond to medication. 
If the initial bleeding episode resolves, the mother and baby 
remain stable, and the foetus is premature, it is reasonable to 
delay delivery.  The goal of this approach is to improve newborn 
outcome by allowing additional time for the baby to develop 
inside the uterus.  Bed rest is usually prescribed, steroids are 
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given to hasten the development of the baby’s lung if needed.  In 
women of negative blood type, an injection of Rh-immune 
globulin is administered.  In patients who remain stable for a 
period of days after an initial episode of bleeding, the need for 
continued hospitalization is controversial. In selected patients 
outpatient management is reasonable following the first episode 
of bleeding.  If bleeding recurs, prolonged hospitalization may be 
necessary. 
C/S is the recommended method of delivery in nearly all 
cases of PP; When possible the procedure should be performed 
electively.  Rarely, in the case of low-lying or marginal placenta 
praevia, the descending foetal head may ‘tamponade’ the bleeding 
placental edge and permit vaginal delivery. In the past, this 
possibility was assessed using a ‘double set-up’ examination in 
which the patients were taken to the operating room and prepared 
for C/S.  A careful examination was undertaken to determine 
whether placental tissue could be seen or felt near the cervix, and 
the method of delivery determined by the findings. 
Today the ‘double set-up’ examination largely has been 
replaced by U/S evaluation of placental location.  C/S for PP can 
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be very difficult and this is why it should be dealt with the most 
senior staff member.  If there is an anterior PP it is better to avoid 
incising through the placenta, and it is almost possible to pass 
around the margins of the placenta.  It is easier usually to bring 
down a foot and perform breech extraction than to try to deliver a 
very high head past the placenta, which occupies the uterine 
wound.  Whatever done, it should be done quickly and efficiently 
as there often foetal blood loss; Delay in delivery may lead to 
foetal compromise.(8) 
After delivery of the baby, removal of the placenta from the 
lower segment may prove difficult.  Because there is a relative lack 
of decidua, an abnormal degree of placental adherence often 
occurs.  Sometimes the placenta has to be removed piece meal and 
the bleeding can be profuse.  An abnormal amount of bleeding 
can also occur because of poor retraction of the less muscular 
lower segment. Insertion of a continuous locked suture in the site 
of placental attachment may be efficacious. If the bleeding is not 
greatly excessive, closing the uterine wound often seems to aid 
retraction.  If control of bleeding proves inadequate despite 
precise suturing, direct pressure with warm packs and the 
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administration of oxytocins are necessary.  Consideration will 
need to be given to ligation of the internal iliac arteries and, 
ultimately to hysterectomy.  The choice of anaesthetic technique 
for C/S for PP must be made by the anaesthetist conducting the 
procedure. General anaesthesia (GA) is easy and quick to perform. 
Studies from USA suggests that regional anaesthesia can be safe. 
Fredrikson et al found in a comparative study done in USA about 
the best type of anaesthesia for C/S due to PP, that, GA increased 
the intraoperative blood loss and the need for BT, and regional 
anaesthesia to be a safer alternative.(27) 
Hong JY et al(28) in a prospective comparison of GA and 
epidural anaethesia in elective C/S for PP totalis to assess 
maternal haemodynaemic, blood loss and neonatal outcome 
found that GA resulted in lowering immediate postoperative 
haematocrit level.  The patients in the general group received a 
significantly larger transfusion than the epidural group. The 
Apgar scores at 1 and 5 minutes were similar in the two groups.  
They concluded that epidural anaesthesia is superior to GA in 
elective C/S for grade 4 PP with regard to maternal 
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haemodynaemics and blood loss. There was no difference in 
neonatal outcome. 
Placenta praevia accreta (PPA): 
Attempts in removing placental tissues may provoke 
massive and fatal haemorrhage. Management depends on the 
parity and the patient's desire for future childbearing.  It is either 
conservation in the form of:- 
• Simple excision of the trophoblastic site with over sewing of 
the area. 
• Pelvic and uterine artery angiographic embolization, this had 
been shown to control otherwise intractable haemorrhage. 
• Uterine artery ligation. 
• Internal iliac artery ligation; bilateral internal iliac artery 
ligation is successful in avoiding hysterectomy in 50% of 
patients with uterine atony and PPH. An experienced 
obstetrician in performing such procedure or a vascular 
surgeon is needed. Fertility is often preserved and subsequent 
pregnancies are not compromised.  
• Medical therapy with methotrexate has been tried with success.  
In these cases placenta (or portions of it) may be left in situ and 
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will later slough off.  Subsequent pregnancies have been 
reported, although the risk of recurrence may be high.   
• There are several case reports of PA in which all or part of the 
placenta was left inside the uterus and managed expectantly.  
This is possible only in patients who are stable.  It should be 
considered in those who understand and accept the risks of 
delayed bleeding and infection. Conservative options may 
provide alternatives to hysterectomy in carefully selected 
patients. In the majority of cases however, hysterectomy 
remains the procedure of choice. 
Hysterectomy:- 
Emergency hysterectomy is a life saving procedure in cases 
of massive uncontrollable bleeding and where the options of 
conservative management have failed.  It is the definitive method 
to control PPH and in 50% of cases it will be the only way to 
achieve haemostasis. 
Yamani Zamzami TY from King Abdelaziz, University 
Hospital in Jeddah, Saudi Arabia, in a review of 17 cases who had 
emergency peripartum hysterectomy among 34,379 deliveries to 
assess the incidence, indications, associated risk factors and 
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complications with emergency peripartum hysterectomy, found an 
incidence of 0.5 per 1000.  Uterine atony 11 (64.7%) (9 without 
praevia and 2 with paevia), morbid adherent placenta with praevia 
6 (35.5%) (one complete placenta accrete and five partial adherent 
placenta) to be the most common indication of hysterectomy. In 
morbid adherent placenta group the gravidity, previous 
miscarriages and prior caesarean deliveries were higher compared 
to the atonic group and were statistically significant. He concluded 
that uterine atony is the leading cause of primary PPH and the 
main indication of emergency peripartum hysterectomy. The 
combination of high parity, C/S, prior caesarean delivery and 
current placenta praevia were identified as risk factors.(29) 
Selo et al(30) to review all emergency peripartum 
hysterectomies performed at a tertiary hospital in London, UK, 
and to identify the risk factors for emergency peripartum 
hysterectomy found an incidence of 0.48 per1000.  Women who 
had emergency peripartum hysterectomy were significantly older 
and multiparous. More of the cases had a history of uterine 
surgery, placenta praevia, and were delivered by C/S.  
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Haemorrhage due to PP was the main indication for emergency 
peripartum hysterectomy (47%). 
Risks and hazards:- 
• Haemorrhage; massive hage either antepartum, intrapartum 
or postpartum associated with PP and PPA is a genuine risk 
and may lead to maternal death. Although complete praevia 
and accreta cases tend to be associated with earlier and more 
severe bleeding, lesser degree of PP may cause life threatening 
haemorrhage thus the degree of placenta is only a factor in the 
prognosis and management.  Blood transfusion with all its 
hazards, namely the infection with human immunodeficiency 
virus (HIV and viral hepatitis are a real problem. Anaemia as 
a consequence of severe haemorrhage is seen in a high 
percentage of these patients. 
Crane JM et al(31) from Canada, in a population based 
retrospective cohort study including all women delivered in the 
Province of Nova Scotia, Canada, from 1988 to 1995 to determine 
the maternal complications of PP. During the 8-year period, 308 
deliveries (0.33%). Maternal complications included hysterectomy 
(RR=33.26), antepartum bleeding (RR=9.81), intrapartum 
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(RR=2.84) and postpartum (RR=1.86) haemorrhages as well as BT 
(RR=10.05) septicaemia (RR=5.55) and thrombophlebitis (RR.4.85). 
The risk factors for need of hysterectomy in women with PP 
include the presence of PA and previous caesarean delivery. 
Anaesthetic complications are more frequent in patients 
with PP and PPA. Ashton et al (32) found that cardiac arrest, 
atelectasis and other anaesthetic complications were frequently 
reported among these patients. 
Postoperative infections; urinary tract infection (UTI), 
respiratory tract infection, and pelvic abscesses are not 
uncommon. 
Pelvic organ injury; because of the emergency nature of the 
procedure and sometimes due to unskilled intraoperative 
manipulation or to invasion by PPA.  The incidence of injury to 
ureter and bladder is 0.3% and 0.1% respectively at the time of 
C/S.  The risk to the bladder is increased 3 fold in repeated C/S, 
and the risk of injury to the ureter can rise 6 fold when caesarean 
hysterectomy is performed. 
Caliskan et al(33)in a case report of 26-year-old woman, with 
one previous delivery and two uterine curettage with the 
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diagnosis of partial P.P at 35 weeks of gestation repeat C/S was 
performed due to profuse bleeding. Placenta praevia percreta 
invading the bladder trigone was confirmed with cystotomy. 
Dilatation of the left ureter was noticed on the second 
postoperative day. Re-laparotomy was performed, and placental 
invasion of the distal left ureter was noticed.  
Ureteroneocystostomy was performed. 
Uterine inversion; this may occur during trial to remove the 
morbidly adherent placenta. 
Torsion of the pregnant uterus; Mendling W(34) reported a        
29-year-old woman with C/S 5 years before, hospitalization in the 
23rd gestational week bleeding by a placenta praevia totalis.  In the 
26 mid gestational week a caesarean re-section was necessary 
because of heavy acute abdominal symptoms. The uterus 
presented torquated for 180 degrees to right. 
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OBJECTIVES 
 
• To determine the incidence, define the risk factors and to 
evaluate maternal and foetal outcome of major placenta 
praevia.   
• To compare between two studies conducted among two 
different groups of patients in two different countries.  
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METHODOLOGY 
Study design: 
This is a prospective, hospital based case-control study.  
Study period: 
The first group was conducted from July 1999 to June 2003.  
 The second group was carried from 1st January 2005 to 31st 
August 2005.  
Study area:  
The study was carried in two different countries, At Al 
Kharj Military Industries Corporation Hospital (AKMICH), 
Kingdom of Saudi Arabia (KSA) and the three teaching hospitals 
in Khartoum State (Sudan), which are Khartoum Teaching 
Hospital (KTH) and Omdurman Maternity Hospital (OMH) and 
Soba University Hospital (SUH). 
AKMICH is a general hospital in the central part of KSA 
with all specialties. The Obstetric and Gynaecology Department 
consists of 40 beds, including obstetric ward, Gynaecology ward 
and labour ward, which is run by three consultants, three senior 
registrars and five registrars. The total number of deliveries is 2500 
per annum.  
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Soba University Hospital (SUH) in Soba town, South-east 
Khartoum city, the capital of Sudan.  
The hospital provides health services in all branches of 
medicine for the patients in the town of Soba and its surrounding 
towns and villages as well as patients with high risk pregnancies 
referred by consultants from other hospitals. The hospital is in run 
by Khartoum University staff.  
It has an Obstetric and Gynaecology Unit, 30 beds for 
antenatal admission, 12 beds for vaginal deliveries and 12 beds for 
gynaecology. The total annual deliveries are between 2500 – 4000 
deliveries.  
Omdurman Maternity Hospital (ONH): covers a wide area 
urban and rural parts of Khartoum State, it accept booked, referred 
and casualty patients. The Department of Obstetric and 
Gynaecology in this hospital is covered by senior consultants, 
junior consultants, registrars and house-officers. The activities of 
this obstetrics and gynaecology unit involve causalities, in patient 
wards, labour room, major and minor theatres and referred clinics.  
The number of deliveries is 10 – 12 × 106 per year.    
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Khartoum Teaching Hospital (KHT) is the largest hospital 
in Sudan. It receives all sorts of patients not only from Khartoum 
city and the surrounding area, but also from all over Sudan. It 
accepts booked, referred and casualty patients.  
The Department of obstetric and Gynaecology in KTH 
consists of six units covered by senior consultants from both 
Ministry of Health and from Faculty of Medicine, University of 
Khartoum, and by resident registrars and house-officers. Each of 
the six units covers the causality and the labour room for 24 hours 
and Fridays by rotation. Every working day of the weeks except 
Friday, each unit covers one day referred clinic and one day 
theater for cold obstetric and gynaecological cases.  
Both the referred clinic and the theater are attended by 
consultants, registrars and house-officers. In the labour room the 
intrapartum care is provided by the registrars and house-staff ion 
duty. The majority of vaginal deliveries are performed by well 
trained midwives and attended by the registrars. In the hospital 
there is a good Neonatal Care Unit covered by resident pediatrics 
registrars, house-officers and well-trained sisters under the 
supervision of a senior pediatrician. 
  29
In the hospital there are blood bank facilities available 24 
hours a day and a well equipped theater with three operating 
rooms for elective and emergency obstetric and gynaecological 
operations.  
The operating room has a caesarean section response 
capability from decision to incision of about 30 minutes. In the 
theater the anesthesia is conducted by 24 hours resident 
anaesthetic registrars and by anaesthetic medical assistants and on 
call consultants.        
Study population:- 
 The study population were two groups of patients. The first 
group were 64 women with major placenta praevia recruited from 
Kingdom of Saudi Arabia (KSA). The second group were 52 
women with major placenta praevia recruited from hospitals in 
Khartoum State.  
Inclusive criteria: 
1- Women with antenatal ultrasound diagnosis of major 
placenta praevia.  
2- Women discovered to have major degree placenta praevia 
intraoperatively.  
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Data collection and analysis:- 
 A questionnaire was designed to include:- 
• Patient’s name, age, residence. 
• Patient’s obstetric & gynaecological history (parity, previous 
scar, previous miscarriages, previous D & C). 
• History of current pregnancy (GA at delivery, APH, BT, PPH). 
• The mode of delivery (emergency, c/s or elective c/s). 
• Maternal complications and outcome. 
• Neonatal outcome (weight, sex, Apgar Score, neonatal 
infection, admission to SCBU & NND). 
Data was collected and analyzed by the computer using 
Statistical Package for Social Sciences (SPSS) for window. 
Key words:-  
 Placenta praevia, placenta accreta, risk factors, caesarean 
section, maternal and neonatal complications. 
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RESULTS 
 
In the first group of this study, the total number of patients 
delivered during the period of the study between 10/07/1999 and 
30/06/2003 were 12600. During the same period a total of 1810 
C/S were performed (14.4%).  
Sixty four patients had C/S due to placenta praevia major, 
giving an incidence of 0.5% of the total deliveries.  
The control group of this study was based on labour ward 
register of 128 patients delivered before and after the index 
pregnancy and did not have P.P.  
Caesarean section for P.P accounted for 3.2% of all the C/S. 
Out of these who had P.P major, 15 (23.3%) patients were operated 
on electively and 49(76.6%) were done as an emergency (Table 1).  
Sixty-two (96.9%) of the C/S due to major P.P were lower 
segment C/S, while only two (3.1%) patients had classical C/S  
(Table 2).  
In the second group of the study, the total number of 
deliveries during the period between 01/01/2005 to 31/08/2005 
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were 18390, and the total number of C/S during the same period 
were 4958 (27%).  
Fifty two patients had C/S due to P.P major, giving an 
incidence of 0.28% of the total deliveries.  
The control of this group were 104 patients delivered by 
C/S during the period of the study and had no P.P. 
In this group 17 (32.7%) patients were operated on 
electively, while 35 (67.3%) were done as an emergency (Table 1).  
Out of these 52 C/S, one was done as a classical C/S, while 
the other (51 cases) were lower segment C/S (Table 2).  
The majority of patients, 39(60.9%) with P.P in the first 
group were in the parity group 4-8, whereas the majority, 68 
(53.1%) of the control group were in the parity group 1-4. The 
mean parity was 4.7± 3.2 and 3.4 ± 2.5 respectively.  This shows 
that there is a significant association between parity and the risk of  
P.P (P= 0.006).  
In the second group of the study, 18(34.6%) patients of the 
study cases were in the parity group >4, compared to only 8(7.7%) 
patients of the study control. The mean parity of this group was 
2.12± 0.758 and 1.80 ±0.564 respectively.  
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This association between increasing parity and 
development of P.P was statistically highly significant (P=0.000) 
(Table 3).   
Forty (62.5%) patients from the first group of the study 
were in the age group 30-39 years, with the mean age of  32.6 ± 5.9 
year, while the majority of the control group lie in the age group 
20-29 years with the mean age  of 29.3 ± 6.1 years,  71(55.5%).  
The study cases were significantly older than their control 
counterparts (P= 0.001). This statistically significant association 
between elder age and P.P was also confirmed in the second study, 
34(65.4%) of the study cases were in the age group 30-39 years, 
while the majority of the control 57(54.8%) were in the age group 
20-29 years (P=0.004) (Table 4).  
In the first group a total of 31 (48.4%) patients had one or 
more previous C/S, while 33(51.6%) patients had no previous C/S.  
In the second group a total of 30(57.7%) patients had one or 
more previous C/S, while 22 (42.3%) patients had no previous 
C/S. Previous C/S was statistically significant as a risk factor for 
P.P in this group (P = 0.038) (Table 5).  
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Concerning the relationship between previous miscarriages 
and/or sharp curettage and P.P, 26(40.6%) patients in the first 
group had one or more previous miscarriages and/or sharp 
curettage compared to 43(33.5%) of the control group. In this 
group the relationship was not significant (P=0.212).  
The second study also did not find significant statistical 
correlation between previous miscarriages and/or sharp curettage 
and the development of P.P, 12 (23.1%) patients had one or more 
previous miscarriages and/or sharp curettage. Compared to 25 
(24.0%) of the control (P= 0.531) (Table 6).  
Concerning the gestational age at delivery in the first study 
group, there was significant difference in the mean gestational age 
at delivery between the cases and control (35.72 ± 3.73 vs 39.10 ± 
2.25) years (P = 0.000). This significant difference was also found in 
the second group. The mean gestational age for the cases were 
35.12±2.61 compared to 38.40 ±1.54 for the control (P = 0.000). In 
both groups, patients with P.P deliver earlier than their control 
counterparts  (Table 7).  
The incidence of placenta accreta was 0.05% (7 cases) in the 
first group. Five (71.4%) of them had previous two or more C/S, 4 
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(57.1%) patients from this group had caesarean hysterectomy. In 
the other 3 (42.9%) patients, the placenta was removed in pieces. 
In the second group the incidence of P.A was found to be 
0.03% (6 cases), all of them had previous two or more C/S, and all 
of them undergone caesarean hysterectomy. One more patient 
from this group had C. hysterectomy because of severe PPH with 
P.P (Table 8).  
One patient from the second group died as a result of 
massive haemorrhage (1.9%) (Table 8), this was a para 4 with a 
history of two previous caesarean sections. She presented with 
vaginal bleeding at 35 weeks gestation, when she was admitted as 
a case of major placenta praevia. She has been in the hospital until 
she bled at 38 week gestation. An emergency lower segment 
caesarean section was performed. Placenta praevia percreta 
invading the bladder wall was only detected at the time of the 
operation. She developed severe postpartum haemorrhage and 
emergency caesarean hysterectomy was performed. She had to be 
opened twice for uncontrollable haemorrhage and eventually died 
having received 17 units of blood.   
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Regarding obstetric haemorrhage (antepartum, 
intrapartum, postpartum), 21 (32.8%) patients in the first group 
had massive obstetric haemorrhage, all of them received BT, one 
needed admission to ICU. Whereas in the second group 33(63.5%) 
patients had massive obstetric haemorrhage and needed 
transfusion (Tables 9 and 10, Figures 1, 2).  
Table 11 shows the distribution of postpartum Hb in both 
studies of major P.P. In the first study patients who had 
postpartum Hb less than 10 gm/dl were 34(53.1%) compared to 
14(10.9%) of their control.  
The study cases had significant lower postpartum Hb than 
has their control (P= 0.000). This significant reduction in 
postpartum Hb was also shown in the second study, 32(61.5%) of 
the study cases had postpartum Hb less than 10 gm/dl compared 
to only 12(11.5%) of the control (P = 0.000).  
Table 12 shows the female, male distribution in both 
studies. In the first group of the study, the female/male ratio was 
35(52.9%) to 32 (47.8%) compared with 68(53.1%) to 60 (46.9%) for 
the control (P= 0.480). In the second group the ratio was 29 (51.8%) 
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to 27(48.2%) and 50(48%) to 54 (52%) respectively (P-= 0.389). 
There was no statistically significant difference in both studies.  
Table 13 shows the methods of anaesthesia used in both 
studies. In the first study, 42(65.6%) operations were done under 
general anaesthesia and 22(34.4%) operations were done under 
spinal anaesthesia, whereas in the second study general 
anaesthesia was used in 16 (30.8%) patients, and spinal anaesthesia 
in 36 (69.2%) patients (Fig. 3).    
Table 14 shows foetal presentation in P.P, P.A cases. In the 
first study cephalic presentation was found in 48 (75%) of the 
study cases and 16 (25%) were non-cephalic presentation 
compared to 122 (95.3%) and 6 (4.7%) respectively in the control 
group. This difference was statistically highly significant                 
(P = 0.000).  
In the second study, cephalic presentation was found in 38 
(73.1%) of cases and 14 (26.9%) were non-cephalic presentation 
compared to 90 (86.5%) and 14(13.5%) in the control group. There 
is a significant correlation between non-cephalic presentation and 
P.P (P = 0.035).   
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Table 15 shows the perinatal outcome in both studies. In 
the first group of the study 22 (32.8%) babies were premature 
(delivered before 37 weeks gestation) compared to 5 (3.9%) in the 
control group. This difference was statistically significant                   
(P =  0.000).  
Regarding admission to SCBU, NICU, 22 (32.8%) of the 
study cases were admitted to SCBU, NICU for varying indications 
compared to 6 (4.7%) in the control group. Fifteen (22.4%) babies 
were born with Apgar score <7 at 5 minutes in the study cases 
compared to 7 (5.55) in the control group.  
There was a significant difference between the cases and 
controls regarding admission to SCBU, NICU and Apgar score < 7 
at 5 minutes (P = 0.000 and  0.001) respectively.  
There was no significant difference in perinatal mortality 
between the study cases and control, 5 (7.5%) vs 3 (2.3%)                  
(P = 0.089).  
In the second group of the study there were 24 (42.9%) 
babies born prematurely (<37 weeks gestation ) compared to only 
3 (2.9%) cases in the control group. This difference was statistically 
highly significant (P = 0.000).  
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Regarding admission to SCBU, NICU, 23 (41.1%) babies 
needed admission compared to 7 (6.7%) of the control. This 
difference was statistically highly significant (P = 0.000). 
Fifteen (26.8%) babies had Apgar score <7 at 5 minutes, 
compared to 11 (10.6%) of the control. This difference was 
statistically significant (P = 0.007). 
Regarding perinatal loss 13(23.2%) babies were died either 
in utero or in early neonatal period, compared to only 3 (2.9%) of 
the control. This difference was statistically highly significant           
(P = 0.000).  
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Table 1: Distribution of the study population according to the 
time of C/S in placenta praevia cases 
C/S First group 
n              (%) 
Second group 
n                (%) 
Emergency  49    ( 76.6%) 35        (67.3%) 
Elective  15    ( 23.4%) 17       (32.7%) 
Total  64    ( 100%) 52        (100%) 
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Table 2: Distribution of the study population according to the 
type of C/S in placenta praevia cases 
C/S First group 
n              (%) 
Second group 
n                (%) 
Lower segment C/S 62    ( 96.9%) 51       (98.1%) 
Classical C/S 02     ( 3.1%) 01       (1.9%) 
Total  64    ( 100%) 52        (100%) 
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Table 3: Correlation between parity and placenta praevia 
First group Second group Parity group 
Case Control Case control 
Nullipara  04 (6.3%) 13 (10.2%) 12 (23.1%) 29 (27.9%) 
1 – 4 21 (32.8%) 68 (53.1%) 22(42.3%) 67 (64.4%) 
> 4 39 (60.9%) 47 (36.7%) 18 (34.6%) 8 (7.7%) 
Total  64 (100%) 128 (100%) 52 (100%) 104 (100%) 
                                          P = 0.006                                   P= 0.000 
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Table 4: Correlation between maternal age and placenta praevia  
First group Second group Age group  
(in years) Case Control Case control 
< 20  02 (3.1%) 02 (1.6%) 01 (1.9%) 08 (7.7%) 
20 – 29  16 (25%) 71 (55.5%) 17 (32.7%) 57 (54.8%) 
30 – 39 40 (62.5%) 47 (36.7%) 32 (61.6%) 37 (35.6%) 
>40 06 (9.4%) 08 (6.3%) 02 (3.8%) 02 (1.9%) 
Total  64 (100%) 128 (100%) 52 (100%) 104 (100%) 
                            P = 0.001                                 P= 0.004 
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Table 5: Incidence of major placenta praevia cases in relation 
to previous C/S 
Previous C/S First group 
n         (%) 
Second group 
n        (%) 
No  33   (51.6%) 22   (42.3%) 
One  15   (23.4%) 08    (15.4%) 
Two  06    ( 9.4%) 12   (23.1%) 
Three  03    ( 4.7%) 08   (15.4%) 
Four  04     ( 6.3%) 02     (3.8%) 
Five  03    ( 4.7%) 0      (0.0%) 
Total  64    ( 100%) 52   (100%) 
                                                                                 P= 0.038 
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Table 6:  Previous miscarriage and/or sharp curettage 
in relation to placenta praevia 
First group Second group Miscarriage + D & C 
 Case Control Case control 
No  38 (59.4%) 85 (66.5%) 40 (76.9%) 79 (76%) 
Previous one or more  26 (40.6%) 43 (33.5%) 12 (23.1%) 25 (24%) 
Total  64 (100%) 128 (100%) 52 (100%) 104 (100%) 
                                               P = 0.212                              P= 0.531 
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Table 7:  Distribution of gestational age at delivery in relation to 
placenta praevia 
First group Second group Gestational age 
 (in weeks) Case Control Case control 
< 32 10 (15.6%) 0 (0.0%) 05 (10.6%) 02 (1.9%) 
32 - 36  21 (32.8%) 07 (5.5%) 31 (69.6%) 09 (8.7%) 
≥ 37 33 (51.6%) 121 (94.5%) 16 (30.8%) 93 (89.4%) 
Total  64 (100%) 128 (100%) 52 (100%) 104 (100%) 
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Table 8: Distribution of accreta cases in relation to previous C/S 
Previous C/S First group 
n          (%) 
Second group 
n        (%) 
No  02     (28.6%) 01  (16.7%) 
One  0      (0.0%) 0      (0.0%) 
Two  01    ( 14.3%) 01   (16.7%) 
Three  01     ( 14.3%) 02    (33.4%) 
Four  02    ( 28.6%) 02     (33.4%) 
Five  01     ( 14.3%) 0       (0.0%) 
Total  07     ( 100%) 06     (100%) 
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Table 9: Incidence of obstetric haemorrhage in relation 
to placenta praevia 
Blood loss First group 
n          (%) 
Second group 
n        (%) 
Mild (500  - 1000) 10     (15.6%) 24  (46.2%) 
Moderate (1001 – 1500) 07     (10.9%) 08      (15.4%) 
Severe (>1500) 04       (6.3%) 01   (1.9%) 
Total  21     (32.8%) 33    (63.5%) 
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Table 10: Rate of blood transfusion in placenta praevia   
Rate  First group 
n          (%) 
Second group 
n        (%) 
No transfusion  43     (67.1%) 19   (36.5%) 
1- 2 unit 12    (18.8%) 19      (36.5%) 
3- 4 units  06    (9.4%) 09      (17.4%) 
> 4 units 03       (4.7%) 05        (9.6%) 
Total  64     (100%) 52    (100%) 
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Table 11: Distribution of postpartum haemoglobin 
in  placenta praevia 
First group Second group Hb (g/dl) 
 Case Control Case control 
8 - 9  07 (10.9%) 0 (0.0%) 13 (25%) 0 (0.0%) 
8.1 – 10.0  27 (42.2%) 14 (10.9%) 19 (36.5%) 12 (11.5%) 
10.1 - 11 20 (31.3%) 62 (48.5%) 20 (38.5%) 51 (49%) 
>11 10 (15.6%) 52 (40.6%) 0 (0.0%) 41 (39.5%) 
Total  64 (100%) 128 (100%) 52 (100%) 104 (100%) 
                                      P = 0.000                         P= 0.000 
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Table 12: Female, male distribution in relation to placenta 
praevia 
First group Second group Sex 
 Case Control Case control 
Female   35 (52.9%) 68 (53.1%) 29 (51.8%) 50 (48.1%) 
Male  32 (47.1%) 60 (46.9%) 27 (48.2%) 54 (51.9%) 
Total  67 (100%) 128 (100%) 56 (100%) 104 (100%) 
                                        P = 0.480                               P= 0.389 
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Table 13: Methods of anaesthesia used in C/S for  
placenta praevia 
Method of anaesthesia First group 
n          (%) 
Second group 
n        (%) 
Spinal   22    (34.4%) 16   (30.8%) 
General  42    (65.6%)    36     (69.2%) 
Total  64     (100%) 52    (100%) 
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Table 14:  Foetal presentation in placenta praevia 
First group Second group Presentation 
 Case Control Case control 
Cephalic  48 (75%) 122 (95.3%) 38 (73.1%) 90 (86.5%) 
Non-cephalic  16 (25%) 6 (4.7%) 14 (26.9%) 14 (13.5%) 
Total  64 (100%) 128 (100%) 52 (100%) 104 (100%) 
                                           P = 0.00                             P = 0.035 
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Table 15:  Perinatal outcome in placenta praevia 
First group Second group Perinatal parameters 
 Case Control Case control 
Age < 37 weeks  22 (32.8%) 05 (3.9%) 24 (42.9%) 3 (2.9%) 
Admission to SCBU, 
NICU  
 
22 (32.8%) 
 
06 (4.7%) 
 
23 (41.1%) 
 
07 (6.7%) 
Apgar Score < 7 at 5 min. 15 (22.4%) 07 (5.5%) 15 (26.8%) 11 (10.6%) 
NND  04 (6.0%)  1 (0.9%)  10 (17.9%)  03 (2.9%)  
IUFD 01 (1.6%)  02 (1.6%) 03 (5.4%)  0 (0.0%)  
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Table 16: Complications related to placenta praevia 
Complications First group 
n          (%) 
Second group 
N        (%) 
No complications 27    (42.2%) 19   (36.5%) 
Obstetric haemorrhage 21   (32.8%) 33     (63.5%) 
Anaemia 18   (28.1%) 32    (61.5%) 
Caesarean  hysterectomy  04   (6.3%) 06     (13.5%) 
Abruptio placenta 02   (3.1%) 03     (5.8%) 
IUFD 01   (1.6%) 03     (5.4%) 
NND 04   (6.0%) 10     (17.9%) 
Maternal deaths  0   (0.0%) 1     (1.9%) 
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DISCUSSION 
 
The study was designed to assess the risk factors and to 
identify the maternal complications and neonatal outcome. 
The incidence of FF in this study was 5 per 1000 (1 in 200) in 
the first group and 2.8 per 1000 (1 in 357) in the second group. 
The explanation for this low incidence of PP in the second 
group of the study compared to the first group could be the high 
parity status in Saudi Arabia (mean parity was 4.7 ± 3.2 vs           
3.4 ± 2.5). 
Lyasu and Co-workers (1993) also found the PP 
complicated 5 in 1000 deliveries (1 in 200).(12) 
Frederiksen and colleagues (1999) reported an incidence of 
5.5 per 1000 (1 in 180) deliveries.(28) 
Crane and associates (1999) found the incidence to be 3.3 
per 1000(1 in300).(36) 
At Parkland Hospital in USA, the incidence was 2.6 per 
1000 (1 in 390) for more than 169000 deliveries over 12 years.(37) 
The incidence of accreta in our study was 0.5 per 1000 in the 
first group and 0.3 per 1000 in the second group. It occurred in 109 
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per 1000 of patients with major PP in the first group and 115 
per 1000 patients with PP in the second group.  
Khouri and Sultan in 1996 reported an incidence if 96 per 
1000 patients with major PP.(38)  
Clark et al(11) reported an incidence of 101 per 1000 patients 
with major PP.  
Parity:  
Both study groups show significant correlation between 
high parity and PP (P = 0.001 in the first group and P = 0.004 in the 
second group). This was consistent with what has been found by 
Archibong, et al who found that increasing parity was associated 
with increased risk of development of PP, but Clark et al found 
that the effect of parity was much less dramatic.(39,10) Gilliam et al 
demonstrated that the joint effect of parity and prior C/S was 
greater than that of either variable alone.(40)  
Age:  
In both studies there was highly significant correlation 
between elder maternal age and PP (P = 0.001 for the first group 
and P = 0.004 for the second group), this finding was supported by 
Lyasu et al who found the incidence of PP to be higher in women 
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aged 35 years or more the in women less than 20 years, in 
contradiction to Zaki et al who found no significant association 
between advanced maternal age and the development of PP, 
PA.(11,12) 
Previous C/S:  
In both groups of the study, the occurrence of PP was found 
among those with one or more previous C/S (48.4% and 47.7%). 
 In the accreta group 71.4% and 83.5% had more than two 
previous C/S (Tables 5 & 8). The explanation could be the uterine 
scaring associated with caesarean section delivery has resulted in 
endometrial and myometrial damage, defective implantation 
mechanism, and failure of differential growth of the scarred lower 
uterine segment, all of which predispose to low implantation of 
the placenta.(41) 
Pregnancies complicated with PP and history of C/S are 
well known to be at increased risk for PA.(11)  
Lydon- Rochelle et al,(41) found a 40% increased risk of PP at 
second birth for women with first birth caesarean delivery 
compared with women with prior vaginal deliveries.  
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Meller et al, found the risk of PA ranged from 2% in women 
< 35 years with no previous C/S deliveries to almost 39% in 
women with two or more C/S deliveries.(10) 
Our study also confirmed the findings of others, that prior 
C/S is an independent risk factor for PP and PA.   
Previous miscarriages and/or sharp curettage:  
In our series we did not find any significant relationship 
between previous miscarriages or previous sharp curettage with 
PP and PA.  
Einola et al found a relation.(15) Johnson et al(14) found that, 
the risk of PP may be increased in close response fashion by 
multiple sharp curettage miscarriages.    
Presentation:  
In this study abnormal presentation was an obvious 
findings in both groups (25% and 26.9%) respectively compared to 
4.7% and 13.5% for the controls. This could be explained by 
prematurity and placental location. Layasu et al(12) found an 
association between PP and foetal malpresentation.   
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Sex:  
Regarding sex ratio of fetuses in association with PP, PA 
there was no difference from their controls in both groups of the 
study. Female : male was 52.9% : 47.8% vs 51.8% : 48.2% for the 
cases and 48.0% : 52.0% vs  51.8 : 48.2% for the controls.  
The sex of the babies was not found to have any significant 
relation with PP, PA in our study.  
Jakobovits and Zubek(42) found preponderance of male 
babies with PP.  
Wen SB et al,(43) reported that pregnant women with male 
babies carry a higher risk of PP. 
Anaesthesia:   
General anaesthesia was the preferred method of 
anaesthesia for patients with PP in both groups of the study (65.6% 
and 69.2%) compared to (34.4 and 30.8%) for spinal anaesthesia. 
Frederiksen et al, found no difference in anaesthetic or 
operative complications with regional as comparing with GA, but 
they found the mean number of units of blood transfused was 
significantly more for the C. hysterectomy group under GA as 
compared with group under regional anaesthesia.(28)  
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Recent UK and American retrospective studies have 
compared regional and general anaesthesia for C/S with placenta 
praevia. 
Regional anaesthesia was associated with reduced 
estimated blood loss and transfusion requirements. The commonly 
held obstetric view that placenta praevia dictates general 
anaesthesia was not supported. However, anterior placenta 
praevia in a woman over 35 who has undergone previous C/S 
suggests a particularly high risk of placenta accreta and massive 
haemorrhage. General anaesthesia with previous for postoperative 
ICU admission might be considered prudent.(46) 
Maternal complications:  
The most important maternal complications encountered in 
our series were antepartum haemorrhage and postpartum 
haemorrhage, caesarean hysterectomy, need for BT, prolonged 
stay in the hospital and low postpartum Hb (Tables 9, 10,11 & 16).  
It was found that obstetric haemorrhage and mean units of blood 
given per patient were higher in cases of PA when compared to PP 
alone.  
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All the accreta cases in both studies developed obstetric 
haemorrhage and required BT compared to 21.8% and 51.9% of 
praevia alone in the first and second groups respectively, 71.4% in 
the first group and 100% in the second group of accreta cases had 
Caesarean hysterectomy, while only one (1.7%) in the second 
group from praevia alone cases had C. hysterectomy due to 
intractable PPH and non of the first group.  
The second important complication was anaemia, it was 
detected in 28.1% patients in the first group and 61.5% in the 
second group. The mean Hb at discharge was 9.1 ± 1.2 and 10.0 ± 
1.12 respectively.    
Postpartum hospital stay was longer in the second group 
than the first (mean = 10.52 ± 5.20 and 6.52 ± 1.76 days) 
respectively. This is in part because mother of the preterm babies 
in the second group stay longer in the hospital to breastfeed their 
babies, while this is not the case in the first group.  
Neonatal outcome:  
In both studies PP was associated with adverse perinatal 
outcome. Prematurity was significantly higher in cases of PP 
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compared to the control. This could be partly iatrogenic due to 
elective termination by elective C/S.  
The high perinatal mortality encountered in this group of 
patients was mainly due to  prematurity. This was also confirmed 
by Ananth et al,(2) who found neonatal mortality rate that 
associated with PP to be 2 to 4 fold higher compared with 
mortality rate among non-placenta praevia births. Inspite of that 
Salihu et al(44) found improvement in perinatal survival among 
neonates that are complicated by PP, in general, comparing studies 
conducted in 1970s which showed PNMR of 120 – 370 per 1000 
neonates, to studies that covered deliveries in 1990s which showed 
a PNMR of 23 per 1000 neonates with their study in year 2003 
which observed PNMR to 11.8 per 1000 neonates complicated with 
PP (Fig. 4).  
Babies born to women with PP are more likely to have 
Apgar score less than 7 at 5 minutes and to be admitted to SCBU, 
NICU. 
This independent contribution of early delivery on neonatal 
death that is associated with PP remain unexplored and further 
studies are needed to control this confounding factor.  
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Still the rate of perinatal loss among the neonates of the 
second group of the study is high compared to neonates of the first 
group. This can be improved by providing better neonatal 
facilities, resources and good training for the neonatologists and 
nursing staff.   
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CONCLUSION 
 
The following points may serve as conclusion to this study:  
• The majority of patients are of middle age and old age with 
grand-multiparity.  
• Caesarean section scar seems to be a predisposing factor in a 
considerable number of patients.  
• Diagnosis of accreta cases is sometimes difficult and only 
confirmed at operation.  
• Maternal complications rest mainly on caesarean hysterectomy 
and on PPH.  
• Perinatal mortality and morbidity are higher in cases 
complicated with placenta praevia and is due to prematurity 
and its complications. 
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RECOMMENDATIONS 
 
The following recommendations were derived in view of 
the results of this study:   
• Patients with placenta praevia and placenta praevia accreta 
should be considered high risk, compatible blood should 
always be available for such cases before considering C/S. 
• Strategies and protocols should be settled to reduce the rate of 
C/S as its association with subsequent development of PP, PA 
was confirmed.      
• Senior obstetric staff should always be available and involved 
in the management of cases of PP especially those at high risk 
of PA.  
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ﻡﻴﺤﺭﻟﺍ  ﻥﻤﺤﺭﻟﺍ  ﷲﺍ  ﻡﺴﺒ 
University of Khartoum 
Faculty of Medicine 
Postgraduate Medical Studies Board 
Questionnaire to assess the risk factor of Major PP maternal 
complication and neonatal outcome 
  
Serial No.:......................      Name:.....................…………………..................     
1- Age (in years):           i- < 20                     ii- 20-29                   iii-  30 -39 
                                           ii- 40-49  
2- Residence:                  i- Rural                      ii- Urban            
 
Antenatal factors 
3- Parity:    i- Nulliparous                  ii. 1- 4                iii. > 4  
4- Order of pregnancy:                     i- Single             ii. Multiple               
5- Gestational age at delivery: …………………..…………………. (weeks) 
6- History of APH:          i- Yes                  ii- No   
If  "Yes" blood loss:………………..…..…… (ml)              
                 Blood transfusion: ……………… (units)   
7- Previous C/S:          i- Yes                      ii- No  
 If  "Yes" Number:  - 1             - 2                - ≥3 
8- Previous miscarriage:          i- Yes               ii- No  
9- Previous D & C:                     i- Yes               ii- No  
10- Anemia with pregnancy:    i- Yes               ii- No  
- Antenatal haemoglobin: ……………………………. (g/dl) 
 
Intrapartum and postpartum factors 
11- Mode of delivery:    i- Emergency C/S                  ii. Elective C/S  
12- History of PPH:       i- Yes                 ii- No   
If  "Yes" blood loss:………………..…..…… (ml)              
  79
                 Blood transfusion: ……………… (units)   
13- Type of anaesthesia:                      
i. General                 ii. Spinal               iii. Others               
14- Postpartum Hb: …………………………………..(gm/dl) 
15- Postpartum hospital stay: ……………….……… (days)          
16- Intra and postoperative complication:           
- Hysterectomy                    - Pelvic organ injury              - Infection 
- Admission to ICU               - Maternal death 
  
Neonatal outcome 
17- Birth outcome:    i- Alive                ii. Stillbirth                 iii. NND 
18- Birth-weight (kg):  ……………………………………………………         
19- Apgar score:                      
           i. 1 min               ii. 5 mins                                         
20- Sex:                      i. Male                ii. Female    
21- Admission to NICU:    i. Yes                ii. No 
22- Duration of stay in NICU (days):……………………………… 
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ﻡﻴﺤﺭﻟﺍ  ﻥﻤﺤﺭﻟﺍ  ﷲﺍ  ﻡﺴﺒ 
University of Khartoum 
Faculty of Medicine 
Postgraduate Medical Studies Board 
Questionnaire to assess the risk factor of Major PP maternal 
complication and neonatal outcome 
  
Serial No.:......................      Name:.....................…………………..................     
1- Age (in years):           i- < 20                     ii- 20-29                   iii-  30 -39 
                                          ii- 40-49  
2- Residence:                  i- Rural                      ii- Urban            
 
Antenatal factors 
3- Parity:    i- Nulliparous                  ii. 1- 4                 iii. > 4  
4- Order of pregnancy:                     i- Single              ii. Multiple               
5- Gestational age at delivery: …………………..…………………. (weeks) 
6- History of APH:          i- Yes                  ii- No   
If  "Yes" blood loss:………………..…..…… (ml)              
                 Blood transfusion: ……………… (units)   
7- Previous C/S:          i- Yes                      ii- No  
 If  "Yes" Number:  - 1             - 2                - ≥3 
8- Previous miscarriage:          i- Yes               ii- No  
9- Previous D & C:                     i- Yes               ii- No  
10- Anemia with pregnancy:    i- Yes               ii- No  
- Antenatal haemoglobin: ……………………………. (g/dl) 
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Intrapartum and postpartum factors 
11- Mode of delivery:    i- Emergency C/S                  ii. Elective C/S  
12- History of PPH:       i- Yes                 ii- No   
If  "Yes" blood loss:………………..…..…… (ml)              
                 Blood transfusion: ……………… (units)   
13- Type of anaesthesia:                      
i. General                 ii. Spinal               iii. Others               
14- Postpartum Hb: …………………………………..(gm/dl) 
15- Postpartum hospital stay: ……………….……… (days)          
16- Intra and postoperative complication:           
- Hysterectomy                    - Pelvic organ injury              - Infection 
- Admission to ICU               - Maternal death 
  
Neonatal outcome 
17- Birth outcome:    i- Alive                ii. Stillbirth                 iii. NND 
18- Birth-weight (kg):  ……………………………………………………         
19- Apgar score:                      
           i. 1 min                        ii. 5 mins                                         
20- Sex:                      i. Male                          ii. Female    
21- Admission to NICU:    i. Yes                 ii. No 
22- Duration of stay in NICU (days):……………………………… 
  
 
 
